Get our best money-saving hacks and pro tips now

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.9050

-0.1600

(-7.75%)

At close: 04:00PM EDT

1.9200

+0.01

(+0.79%)

After hours:

07:59PM EDT

Loading interactive chart…

Investing.com
Dow futures tick higher, banking crisis weighs
By Oliver Gray
Zacks
Heron Therapeutics (HRTX) Reports Q4 Loss, Tops Revenue Estimates
Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 32% and 13.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
PR Newswire
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced financial results for the three and twelve months ended December 31, 2022 and highlighted recent corporate updates.